$ Orphazyme A/S (ORPH)$ Share prices are rising drastically in Copenhagen, which means that the drug arimoclomol must have been approved or it’s an indication of a good thing that has happened to the company, I would recommend a buy rating looking at the current statistics and price value in US which is around 14-15 currently as it’s bound to shoot up in tonight’s market!!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments